Yayın:
Reversible cerebellar toxicity during treatment with ornidazole: The first case report

dc.contributor.buuauthorTaşkapılıoğlu, Özlem
dc.contributor.buuauthorSeferoğlu, Meral
dc.contributor.buuauthorKaygılı, E.
dc.contributor.buuauthorHakyemez, Bahattin
dc.contributor.buuauthorZarifoğlu, Mehmet
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentNöroloji Ana Bilim Dalı
dc.contributor.departmentRadyoloji Ana Bilim Dalı
dc.contributor.orcid0000-0002-3425-0740
dc.contributor.researcheridAAI-2318-2021
dc.contributor.researcheridAAK-6623-2020
dc.contributor.scopusid23037226400
dc.contributor.scopusid25636262100
dc.contributor.scopusid35778111900
dc.contributor.scopusid6602527239
dc.contributor.scopusid6603411305
dc.date.accessioned2022-03-14T13:36:11Z
dc.date.available2022-03-14T13:36:11Z
dc.date.issued2010-03
dc.identifier.citationTaşkapılıoğlu, Ö. vd. (2010). "Reversible cerebellar toxicity during treatment with ornidazole: The first case report". Journal of Neurology, Neurosurgery and Psychiatry, 81(3), 349-350.
dc.identifier.doi10.1136/jnnp.2009.178897
dc.identifier.endpage350
dc.identifier.issn0022-3050
dc.identifier.issn1468-330X
dc.identifier.issue3
dc.identifier.pubmed20185475
dc.identifier.scopus2-s2.0-77649086044
dc.identifier.startpage349
dc.identifier.urihttps://doi.org/10.1136/jnnp.2009.178897
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/20185475/
dc.identifier.urihttp://hdl.handle.net/11452/25010
dc.identifier.volume81
dc.identifier.wos000274974300029
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherBMJ
dc.relation.journalJournal of Neurology, Neurosurgery and Psychiatry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectNeurosciences & neurology
dc.subjectPsychiatry
dc.subjectSurgery
dc.subject.emtreeAmoxicillin
dc.subject.emtreeLansoprazole
dc.subject.emtreeMetronidazole
dc.subject.emtreeOrnidazole
dc.subject.emtreeSecnidazole
dc.subject.emtreeTinidazole
dc.subject.emtreeAdult
dc.subject.emtreeAtaxia
dc.subject.emtreeBrain disease
dc.subject.emtreeCase report
dc.subject.emtreeCerebellum
dc.subject.emtreeDrug withdrawal
dc.subject.emtreeDysarthria
dc.subject.emtreeGait disorder
dc.subject.emtreeHuman
dc.subject.emtreeLetter
dc.subject.emtreeMale
dc.subject.emtreeNeurotoxicity
dc.subject.emtreeNuclear magnetic resonance imaging
dc.subject.emtreeNystagmus
dc.subject.emtreePeptic ulcer
dc.subject.emtreePeripheral neuropathy
dc.subject.emtreePriority journal
dc.subject.emtreeSeizure
dc.subject.meshAmebicides
dc.subject.meshCerebellar ataxia
dc.subject.meshCerebellar diseases
dc.subject.meshCerebellar nuclei
dc.subject.meshCorpus callosum
dc.subject.meshDiffusion magnetic resonance imaging
dc.subject.meshDrug therapy, combination
dc.subject.meshDysarthria
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMagnetic resonance imaging
dc.subject.meshOrnidazole
dc.subject.meshPeptic ulcer
dc.subject.meshPons
dc.subject.meshTegmentum mesencephali
dc.subject.meshYoung adult
dc.subject.scopusLevofloxacin; Quinolone Derivative; Hallucinations
dc.subject.wosClinical neurology
dc.subject.wosPsychiatry
dc.subject.wosSurgery
dc.titleReversible cerebellar toxicity during treatment with ornidazole: The first case report
dc.typeLetter
dc.wos.quartileN/A
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Nöroloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Radyoloji Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama